Tofacitinib is superior to methotrexate in treating rheumatoid arthritis, but increased side effects were seen with tofacitinib, including development of herpes zoster.
Your search for tofacitinib returned 4 results
Early experimental study shows promise; more research needed
Researchers report that a drug for rheumatoid arthritis may be a promising treatment for vitiligo.
For patients with rheumatoid arthritis (RA), moderate changes in lipids are observed after treatment with tocilizumab or tofacitinib.